Table 5.
Bivariate Analysis of Delay and No Delay in Treatment Onset according to Clinical-Pathological Variables, Brazil, 2015
| Variables | Delay (> 30 days) | No delay (≤ 30 days) | p |
|---|---|---|---|
| n (%) | n (%) | ||
| Tumor stage (n=62) | |||
| I | 1 (50.0) | 1 (50.0) | |
| IIA and IIB | 23 (62.2) | 14 (37.8) | |
| IIIA and IIIB | 13 (61.9) | 8 (38.1) | |
| IV | 1 (50.0) | 1 (50.0) | 0.97 |
| Estrogen receptor (n=68) | |||
| Positive | 34 (63.0) | 20 (37.0) | |
| Negative | 10 (71.4) | 4 (28.6) | 0.45 |
| Progesterone receptor (n=66) | |||
| Positive | 32 (65.3) | 17 (34.7) | |
| Negative | 11 (64.7) | 6 (35.3) | 0.96 |